Form 4: Portage Biotech CEO Buys Shares
Insider Transaction (Form 4)
Brittany Kaiser, Chief Executive Officer and a Director of Portage Biotech Inc., purchased 9,350 shares of common stock on April 29, 2026 for $5.35 per share.
Summary
- Grant/award: acquired 7,416 Ordinary Shares on April 29, 2026; holds 7,416 after (Direct).
- Open-market purchase: acquired 9,350 Ordinary Shares at $5.35 ($49,997) on September 9, 2026; holds 16,766 after (Direct).
- Grant/award: acquired 10,906 Option Shares (right to buy) on May 14, 2026; holds 10,906 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $49,997, committing personal capital to the stock.
Insider Transactions
Brittany Kaiser — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-29 | Grant/award | Ordinary Shares | 7,416 | — | — | 7,416 |
| 2026-09-09 | Open-market purchase | Ordinary Shares | 9,350 | $5 | $50.0K | 16,766 |
| 2026-05-14 | Grant/award | Option Shares (right to buy) | 10,906 | — | — | 10,906 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-29 | Grant/award (7,416 shares) |
| 2026-09-09 | Open-market purchase (9,350 shares) |
| 2026-05-14 | Grant/award (10,906 shares) |
Keywords
insider transaction, Form 4, ALP, Alpha Compute Corp, bullish, Brittany Kaiser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.